Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a study to focus on the feasibility of using a monitor which may signal loss of visual function intraoperatively.
The degree of a relative afferent pupillary defect (RAPD) has been correlated with the severity of an eye injury and has been shown to have prognostic significance as an indicator of retinal ischemia. Therefore light flashed evoked pupillometry (LFEP) may serve as a useful indicator of visual function. LFEP's are not known to be sensitive to anesthetics. We will measure LFEP's using different anesthetic techniques to see if there are measurable differences in the latency, amplitude and constriction velocity of the pupillary reflex. Prior to induction of anesthesia, pupillometer readings will be taken in the supine position in both eyes. The patient will be anesthetised using a standard induction technique. For maintenance of anesthesia a remifentanil infusion will be administered and supplemented by either propofol infusion (at 120 and 160 mcg/kg/min)or sevoflurane (at 1.5 and 2.5% end-tidal in random sequence. The patients will receive muscle relaxants as needed. Pupillometry readings will be taken in both eyes after induction, after steady maintenance has been achieved and every 10 minutes for 30 minutes at each drug dose.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 2. Sevoflurane | Subjects will receive sevoflurane at 1.5% and 2.5% end tidal after steady state maintenance has been achieved and have pupillometry readings taken and every 10 minutes for 30 minute at each drug dose. |
| |
| 1.Propofol | 1.Subjects will receive propofol infusion and have pupillometry readings taken in both eyes after induction, after steady state maintenance has been achieved and at 30 minutes |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| propofol | Drug | Propofol infusion 120 and 160 mcg/kg/min in random sequence during the operative procedure |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measure the pupil response using different anesthetic techniques | pupillometry measurements will be taken in both eyes after induction of anesthesia |
| Measure | Description | Time Frame |
|---|---|---|
| Measure the pupil response using different anesthetic techniques | When steady maintenance of anesthesia drug is obtained measure pupillometry response at 10 min | |
| Measure the pupil response using different anesthetic techniques | When steady maintenance of anesthesia drug is obtaines measure pupillometry response at 20 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
subjects undergoing orthopedic surgery in the supine position
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Geordie P. Grant, MD | Rutgers, The State University of New Jersey | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital | Newark | New Jersey | 07101 | United States |
Not provided
| ID | Term |
|---|---|
| D001766 | Blindness |
| D018917 | Optic Neuropathy, Ischemic |
| ID | Term |
|---|---|
| D014786 | Vision Disorders |
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015742 | Propofol |
| D000077149 | Sevoflurane |
| ID | Term |
|---|---|
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Sevoflurane | Drug | sevoflurane 1.5% and 2.5% end tidal in random sequence |
|
|
| Measure the pupil response using different anesthetic technique | When steady maintenance of anesthesia drug is obtained measure pu[illometry response at 30 minutes. |
| D005128 |
| Eye Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009901 | Optic Nerve Diseases |
| D003389 | Cranial Nerve Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D006838 |
| Hydrocarbons |
| D009930 | Organic Chemicals |
| D008738 | Methyl Ethers |
| D004987 | Ethers |
| D006845 | Hydrocarbons, Fluorinated |
| D006846 | Hydrocarbons, Halogenated |